Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$53,414,866
+$8,659,994 QoQ
Shares Held
212,267
+3.2% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#352
of 4,176 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Federation des caisses Desjardins du Quebec holds $784,151,867 across 18 Drug Manufacturers - General names. ABBV ranks #5 (6.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
1,035,263 | $262,925,742 | |
| 2 | LLY |
ELI LILLY & Co
|
135,322 | $162,309,278 | |
| 3 | PFE |
Pfizer Inc
|
3,414,310 | $82,216,583 | |
| 4 | MRK |
Merck & Co., Inc.
|
514,231 | $66,078,682 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
212,267 | $53,414,866 | |
| 6 | AZN |
Astrazeneca PLC
|
209,951 | $39,810,907 | |
| 7 | SNY |
Sanofi
|
873,273 | $37,253,825 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
214,642 | $27,117,868 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $53,414,866 | 212,267 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $44,754,872 | 205,779 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $47,708,482 | 208,799 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $38,012,151 | 164,171 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $30,855,981 | 166,232 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $34,677,443 | 165,509 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $26,726,790 | 150,404 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $46,250,999 | 234,206 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $40,037,912 | 233,430 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $35,982,777 | 197,599 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $29,129,555 | 187,969 | Shares | Defined | 2024-08-15 | |
| 2023-09-30 | $27,850,518 | 186,841 | Shares | Defined | 2024-08-15 | |
| 2023-06-30 | $24,053,615 | 178,532 | Shares | Defined | 2024-08-15 | |
| 2023-03-31 | $30,103,399 | 188,890 | Shares | Defined | 2024-08-15 | |
| 2022-12-31 | $25,973,312 | 160,716 | Shares | Defined | 2024-08-15 | |
| 2022-09-30 | $26,808,178 | 199,748 | Shares | Defined | 2024-08-15 | |
| 2022-06-30 | $30,272,686 | 197,654 | Shares | Defined | 2024-08-15 | |
| 2022-03-31 | $32,683,807 | 201,615 | Shares | Defined | 2024-08-15 | |
| 2021-12-31 | $33,645,681 | 248,491 | Shares | Defined | 2024-08-30 | |
| 2021-09-30 | $26,320,279 | 244,000 | Shares | Defined | 2024-08-30 | |
| 2021-06-30 | $25,889,740 | 229,845 | Shares | Defined | 2024-08-30 | |
| 2021-03-31 | $24,649,485 | 227,772 | Shares | Defined | 2024-08-30 | |
| 2020-12-31 | $22,503,749 | 210,021 | Shares | Defined | 2024-08-30 | |
| 2020-09-30 | $15,181,449 | 173,324 | Shares | Defined | 2024-08-30 | |
| 2020-06-30 | $16,316,534 | 166,190 | Shares | Defined | 2024-08-30 | |
| 2020-03-31 | $11,216,996 | 147,224 | Shares | Defined | 2024-08-30 | |
| No filing history on record for this holder in this stock. | ||||||